non-clinical trial institute
Scope
Date
~
-
Bio & Pharma
S.Biomedics gets approval for Parkinson's disease clinical trials
South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...
Jan 13, 2023 (Gmt+09:00)
-
Bio & Pharma
GCCL develops Korea's first automatic clinical trial data sharing system
Global Clinical Central Lab (GCCL), an affiliate of South Korean pharmaceutical firm Green Cross Corp., said on Monday it has jointly developed Kore...
Jan 10, 2023 (Gmt+09:00)
-
Economy
Seoul ranks 7th in city competitiveness assessed by Japanese Institute
Seoul's urban competitiveness rebounded after five years, ranking seventh in the world. It was due to the fact that the ranking of the economy categ...
Jan 09, 2023 (Gmt+09:00)
-
Banking & Finance
KEXIM bank issues $3.5 billion in foreign currency bonds
The Export-Import Bank of Korea on Thursday said it issued a record-high $3.5 billion in global bonds to investors worldwide.The government-run bank...
Jan 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments
Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Medicox, Oramed sign MOU to enlist more institutional investors
South Korea's biomedicine firm Medicox Co. said on Monday that it had signed a strategic memorandum of understanding (MOU) with Oramed Pharmaceutica...
Jan 02, 2023 (Gmt+09:00)
-
Banking & Finance
Shinhan Bank to completely scrap mobile, online balance transfer fees
Beginning on New Year's day, Shinhan Bank started waiving all balance transfer fees to other bank accounts and automated transfer fees for its mobil...
Jan 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Pension funds
NPS will intensify shareholder engagement, new CIO says
Seo Won-joo, the new chief investment officer of the National Pension Service (NPS) of South Korea, said on Dec. 27 that the pension fund will stren...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
Medipost's Cartistem shows effects on patellar cartilage defect patients
Medipost's knee osteoarthritis treatment Cartistem has been mentioned in a renowned international journal, showing that it is effective even in pati...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Aerospace & Defense
Hanwha takes over satellite technology from gov't institute
The state-run Korea Astronomy and Space Science Institute (KASI) said on Monday it had transferred to Hanwha Systems Co. the technology for satellit...
Dec 26, 2022 (Gmt+09:00)
-
Banking & Finance
85% of S.Korea's Gen MZ have contactless savings accounts
A study finds 90% of South Korea's Generation MZ, a demographic comprising millennials and Generation Z members born between 1981 and 2010, use cont...
Dec 26, 2022 (Gmt+09:00)
-
Fintech
South Korea doubles gov't fintech innovation fund to $781 million
The South Korean government will double the value of its Fintech Innovation Fund, a source of financial support for the financial technology or fint...
Dec 26, 2022 (Gmt+09:00)
-
Culture & Trends
Korean think tank urges focus on 'yold' demographic in clothing market
South Korea's Samsung Fashion Institute on Thursday announced "Dive In" as the keyword for next year's trends in the fashion industry, meaning that ...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Asset management
US non-agency mortgage-backed securities to shine in 2023: TCW
Amid the tightening of the Federal Reserve, among the most impacted asset classes were agency mortgage-backed securities (MBS), issued by US governm...
Dec 22, 2022 (Gmt+09:00)
-
Korean stock market
Mirae Asset introduces AI investment info service
Mirae Asset Securities Co. said on Tuesday it had introduced two domestic stock artificial intelligence (AI) reporting services through its mobile t...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Automobiles
S.Korea must use Indonesia, Thailand as EV output-export bases: report
The Korea Automotive Technology Institute says the domestic auto industry should more proactively use Asean-region members like Indonesia and Thaila...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma confirms safety of flu vaccine in phase 1 trial
South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm begins clinical trials of wearable device for detecting epilepsy
SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Bio & Pharma
New drug developer Onconic Therapeutics raises $20 mn in Series B
South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...
Dec 09, 2022 (Gmt+09:00)
-
Korean startups
D.Day X D.Camp All Star event aims to narrow gap between VC and startup
Come this Thursday, D.Camp operated by the Banks Foundation for Young Entrepreneurs will host the biggest demo day of the year, in collaboration wit...
Nov 21, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins trial against Regeneron for US patent lawsuit over biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...
Nov 18, 2022 (Gmt+09:00)
-
Corporate bonds
Korean firms at risk of credit rating downgrade on Legoland woes
South Korean companies are at risk of credit rating downgrades as the fallout of a debt default by the domestic developer of a Legoland theme park r...
Nov 13, 2022 (Gmt+09:00)
Latest News
- 1 Korea's Hana Bank to promote foreigners as managers in overseas units
- 2 Samsung to unveil 400-layer bonding vertical NAND for AI servers by 2026
- 3 Korean LPs sharpen eyes on GPs' post-investment management
- 4 LG Energy Q3 profit more than doubles on higher sales
- 5 Kakao Mobility to launch outdoor robot delivery